Search

everythinglearnresearchcommunity

for

Search:↓

Retinoic acid may help heal skin without scars by reducing fibrosis and supporting skin regeneration.

Corticosteroids effectively treated a 60-year-old man's skin condition.

Antimalarial agents are effective for LPP, and intralesional steroids are effective for FFA.

Telogen Effluvium is a common, usually reversible hair loss condition, often improved by removing the trigger and possibly treated with various products, though their effectiveness is uncertain.

Discoid Lupus Erythematosus often causes scarring hair loss, is influenced by genetics and environment, and requires early treatment to prevent worsening.

Early and aggressive treatment of scarring alopecia is important to prevent further hair follicle damage.

Clinical signs don't match inflammation levels in lichen planopilaris and frontal fibrosing alopecia.

The document concludes that accurate diagnosis of ichthyosis is crucial for treatment and genetic advice, and ongoing research is needed for better therapies.

Lupus affects the body and skin, causing joint pain and skin issues that can be treated with steroids and antimalarial drugs.

Obesity is linked to various skin problems and may increase the risk of skin cancer.

Interferon, especially alfa interferon, is an effective treatment for cutaneous T-cell lymphoma with manageable side effects.

The sebaceous gland has more roles than just producing sebum and contributing to acne, and new research could lead to better skin disease treatments.

All-trans retinoic acid causes hair loss by increasing TGF-β2 in hair follicle cells.

Lichen planopilaris is a chronic, scarring hair loss condition with no definitive cure, requiring accurate diagnosis and treatment to manage symptoms.

Hair loss that spreads out can often fix itself or be treated by finding and handling the cause.

Inherited ichthyoses cause widespread skin scaling and thickening due to gene mutations.

Insulin resistance may contribute to various skin diseases and treating it could improve skin health and prevent more serious conditions.

Nuclear hormone receptors play a significant role in skin wound healing and could lead to better treatment methods.

Advanced nanocarrier and microneedle drug delivery methods are more effective, safer, and less invasive for treating skin diseases.

Chronic Telogen Effluvium may resolve after years and is diagnosed by examining the patient's history and clinical signs, with treatment aimed at underlying causes and possibly minoxidil.

An imbalance between certain immune cells is linked to a chronic skin condition and may be influenced by obesity, smoking, and autoimmune issues.

Some systemic treatments work for nail psoriasis but can have serious side effects.

Anti-acne medications may work by reducing the activity of a protein involved in acne development.

Early diagnosis and treatment of discoid lupus erythematosus improve outcomes.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

Hair loss can indicate underlying systemic diseases and addressing these can sometimes reverse the hair loss.

Botulinum toxin shows promise for various skin conditions but requires more research for confirmation and standardized use.

Finasteride increases hair density in female androgenetic alopecia, but individual results may vary.

Dupilumab is being tested for many new skin, respiratory, and gastrointestinal conditions.

Maintaining the right amount of retinoic acid is crucial for healthy hair and skin.